Antimalarial Prophylaxis: Why the Pharmacy Counter Abroad Is the Wrong Place to Start

Buying antimalarials at your destination airport pharmacy costs more, starts too late, and may give you the wrong drug for local resistance patterns.

Antimalarial prophylaxis: what you need to know

Chloroquine resistance was first confirmed in Southeast Asia in the late 1950s, yet travellers still arrive in Phnom Penh or Kampala every week clutching chloroquine they bought at a local pharmacy. Resistance patterns now make chloroquine ineffective in most malaria-endemic regions^[1], and a pharmacist who sells it to you on the way out of the airport is not giving you bad advice out of malice. They simply do not know your destination's current resistance map.

The right antimalarial depends on three things: where you are going, which Plasmodium species circulates there, and how resistant local strains are to specific drugs. None of that information is printed on the pharmacy shelf.

Medical disclaimer: This article provides general travel health information and does not replace personalised medical advice. Malaria risk, drug resistance patterns, and contraindications change over time and vary by individual health status. Consult a qualified travel medicine physician or travel clinic before any trip to a malaria-endemic area. Always carry and take your full prescribed prophylaxis course.

The five drugs in common use and where each one fits

Atovaquone-proguanil (Malarone). is the default first choice for most sub-Saharan African destinations. The CDC recommends atovaquone-proguanil for travellers to areas with chloroquine-resistant P. falciparum^[2], which covers most of Africa south of the Sahara, Papua New Guinea, and parts of South and Southeast Asia. It has one structural advantage over the others: you stop it only seven days after leaving the malaria zone, which suits short trips. The main disadvantage is cost: a 28-day course runs roughly €60-€90 (~$70-$106) at a European travel clinic.

Doxycycline. is the cheapest option and works across the same resistance map as atovaquone-proguanil. Doxycycline is also the recommended prophylaxis for most of Southeast Asia, including the Thailand-Myanmar border region^[3] where mefloquine-resistant strains are now well-documented. Two trade-offs matter: you must take it for four weeks after leaving the malaria zone, and it increases photosensitivity, which is a meaningful issue in tropical sun.

Mefloquine (Lariam). is still a CDC- and WHO-recommended first-line option for chloroquine-resistant areas, taken weekly rather than daily, which travellers with adherence concerns may prefer. It is also the only chemoprophylaxis option currently recommended for pregnant travellers to chloroquine-resistant regions. Mefloquine is contraindicated in anyone with a history of seizures, psychiatric disorders (depression, anxiety disorder, psychosis), or cardiac conduction abnormalities; neuropsychiatric side effects are the main reason it falls behind atovaquone-proguanil or doxycycline as a default for travellers without those contraindications.

Chloroquine. retains a narrow use case: chloroquine-sensitive malaria persists in Central America west of the Panama Canal, Haiti, the Dominican Republic, and most of the Middle East^[4]. Outside those areas chloroquine resistance is near-universal in P. falciparum, and buying it abroad on the assumption it works everywhere is a known failure mode. Tafenoquine (Arakoda) is the fifth and most recently approved option, FDA-cleared in August 2018 for prophylaxis in adults: a 3-day loading dose followed by once-weekly dosing during travel and a single dose 7 days after leaving the malaria zone. Tafenoquine requires quantitative G6PD testing before the first dose because it can cause severe haemolysis in G6PD-deficient patients, in the same mechanism as primaquine. It is effective against both chloroquine- and mefloquine-resistant P. falciparum.

When to start: the window most travellers miss

Starting on the plane is too late for three of the five drugs. Atovaquone-proguanil and doxycycline each need only 1-2 days of lead time, but mefloquine and chloroquine require at least 1-2 weeks before departure, and CDC and WHO both recommend starting mefloquine 3-4 weeks ahead, so any neuropsychiatric side effects emerge while you are still close to home and can switch drugs. Tafenoquine needs a 3-day loading dose immediately before travel.

The WHO recommends booking a pre-travel consultation at least four to six weeks before departure for any itinerary involving malaria-endemic areas^[5]. That window accounts for the mefloquine lead time, allows for any required vaccinations, and gives you time to switch drugs if the first choice causes side effects.

The post-travel tail matters as much as the lead-in. Doxycycline and mefloquine must continue for four weeks after leaving the malaria zone. Atovaquone-proguanil needs only seven days. If you stop any drug the day you board your return flight, you leave a gap that P. falciparum can exploit, since the incubation period runs up to 30 days.

Why buying antimalarials at your destination is a specific risk

Counterfeit and substandard antimalarials remain a documented problem across sub-Saharan Africa and Southeast Asia. Studies published in the Lancet Infectious Diseases have found up to 36% of antimalarial samples in parts of Southeast Asia to be substandard or falsified^[6]. A tablet that contains 40% of the stated active ingredient does not just fail to protect you. It may contribute to resistance.

Beyond counterfeits, local pharmacists are optimising for sales, not for your destination's resistance map or your personal medical history. A pharmacist in Nairobi does not know whether you have a G6PD deficiency, a history of depression, or a skin condition that contraindicated doxycycline. Your travel clinic physician does.

There is also the timing problem: if you arrive in Accra on day one and buy your antimalarials there, you have no lead-in protection at all. You were exposed to Anopheles mosquitoes on the evening of arrival, before your first dose.

Destination-specific drug choices: a quick reference

Sub-Saharan Africa (including Kenya, Tanzania, Ghana, Nigeria, Uganda). First-line options are atovaquone-proguanil or doxycycline. Chloroquine resistance is near-universal in these countries. If you are travelling to Nairobi, the Nairobi healthcare guide covers emergency clinic access if you develop symptoms in-country.

Southeast Asia (Thailand, Cambodia, Vietnam, Myanmar, Indonesia). Doxycycline is the recommended first-line drug for the Thai-Myanmar and Thai-Cambodia border areas, where multidrug-resistant P. falciparum is well-documented. Atovaquone-proguanil is the alternative. Standard beach destinations in Thailand (Koh Samui, Phuket) carry very low malaria risk, and prophylaxis may not be warranted at all. Check the Bangkok healthcare guide for local hospital access.

South Asia (India, Nepal, Sri Lanka, Pakistan). Risk varies significantly by region and season. Rural areas of Odisha and the northeastern Indian states carry P. falciparum risk; most urban tourist circuits do not. Atovaquone-proguanil or doxycycline is appropriate where risk exists. Urban Delhi, Mumbai, and Colombo generally require no prophylaxis for short-stay visitors.

Central America and Caribbean (Mexico, Guatemala, Haiti, Dominican Republic). Chloroquine-sensitive P. vivax predominates in most of Central America and the Caribbean. This is the one region where chloroquine remains appropriate, with chloroquine-plus-primaquine sometimes used for P. vivax eradication. Confirm with a travel clinic, as risk zones shift.

How your medical record affects which drug you can take

Several common conditions directly limit your antimalarial choices. G6PD deficiency is a contraindication to primaquine and tafenoquine^[7]. Mefloquine is contraindicated in anyone with a seizure disorder, cardiac conduction abnormalities, or a history of psychiatric illness. Doxycycline is contraindicated in pregnancy and should be used cautiously in people with oesophageal conditions.

A travel clinic physician reviewing your International Patient Summary can flag these interactions before you travel. Carrying an up-to-date IPS on Nomedic means any clinician abroad, including emergency physicians in Kampala or Bangkok, can see your contraindications in a standardised format without needing to translate your home records.

If you develop a fever in a malaria-endemic area

Any fever within three months of returning from a malaria-endemic area is malaria until proven otherwise. P. falciparum can progress to severe malaria, including cerebral malaria, within 24 hours of symptom onset^[8]. Seek a thick blood film or rapid diagnostic test immediately. Do not wait to see whether the fever resolves.

Prophylaxis reduces the risk of clinical malaria by 90% or more when taken correctly, but it is not 100% protective. Tell any physician you see that you have been in a malaria-endemic area, even if you took your full prophylaxis course.

Frequently asked questions

Can I buy antimalarials when I arrive at my destination?

Buying on arrival means you have no lead-in protection on your first day of exposure. Local pharmacies in endemic areas also have documented rates of substandard and counterfeit products. Obtain your prescription from a travel clinic before you depart.

Which antimalarial is best for East Africa?

Atovaquone-proguanil (Malarone) or doxycycline are the standard first-line options for most of sub-Saharan Africa, including Kenya, Tanzania, and Uganda. Chloroquine is ineffective against the predominant strains in that region and should not be used.

How long do I need to take antimalarials after leaving a malaria zone?

Doxycycline and mefloquine require four weeks of post-travel dosing. Atovaquone-proguanil requires only seven days after leaving the endemic area. Stopping early leaves a gap during the P. falciparum incubation period.

Can I take antimalarials if I am pregnant?

Doxycycline and mefloquine are contraindicated in pregnancy. Atovaquone-proguanil is not recommended due to limited safety data. If you are pregnant and must travel to a high-risk area, discuss chloroquine or the risk-benefit balance with a specialist in travel medicine.

Does my medical history affect which antimalarial I can take?

Yes. G6PD deficiency, epilepsy, cardiac conduction abnormalities, and psychiatric conditions all restrict certain options. A travel clinic physician reviewing your medical record can identify contraindications before you travel.